Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 31, 2014
Effects of OnabotulinumtoxinA treatment for crow's feet lines on patient-reported outcomes
Steven Dayan, William P Coleman, Jeffrey S Dover, et al.
JAAD International
|
November 30, 2023
Safety and tolerability of onabotulinumtoxinA in the treatment of upper facial lines from global registration studies in 5298 participants: A meta-analysis
Mitchell F Brin, Koen De Boulle, Steven Liew, et al.
Journal of the American Academy of Dermatology
|
October 23, 2024
Improvement of platysma prominence with onabotulinumtoxinA: Safety and efficacy results from a randomized, double-blinded, placebo-controlled phase 3 trial
Sabrina Fabi, Shannon Humphrey, Brian Biesman, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 17, 2020
Forehead Line Treatment With OnabotulinumtoxinA in Subjects With Forehead and Glabellar Facial Rhytids: A Phase 3 Study
Steven Fagien, Joel L Cohen, William Coleman, et al.
Aesthetic Surgery Journal
|
March 20, 2025
A Controlled Phase 2b Trial to Assess the Efficacy and Safety of a Single Intervention of OnabotulinumtoxinA for Treating Masseter Muscle Prominence
Steven Liew, Derek Jones, Steven Dayan, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 28, 2014
Efficacy and safety of onabotulinumtoxinA for the treatment of crows feet lines: a multicenter, randomized, controlled trial
Alastair Carruthers, Suzanne Bruce, Arlette de Coninck, et al.
Aesthetic Surgery Journal
|
August 22, 2025
Longitudinal Computed Tomography Indicates No Negative Impact of OnabotulinumtoxinA on Mandibular Bone Density in a 12-Month, Double-Blind, Randomized, Repeat Treatment, Placebo-Controlled Study in Healthy Adults With Masseter Muscle Prominence
Paul Kostenuik, Sanjay M Mallya, René Hopfinger, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
August 11, 2018
Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines
Koenraad De Boulle, William Philip Werschler, Michael H Gold, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 9, 2014
Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial
Marion Moers-Carpi, Jean Carruthers, Steven Fagien, et al.
Infectious Diseases in Clinical Practice (Baltimore, Md.)
|
September 20, 2021
Discontinuation of Transmission Precautions for COVID-19 Patients: Polymerase Chain Reaction Diagnostics, Patient Delays, and Cycle Threshold Values
Rahim A Jiwani, Yuxuan Mao, Adrian Pona, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 31, 2014
Effects of OnabotulinumtoxinA treatment for crow's feet lines on patient-reported outcomes
Steven Dayan, William P Coleman, Jeffrey S Dover, et al.
JAAD International
|
November 30, 2023
Safety and tolerability of onabotulinumtoxinA in the treatment of upper facial lines from global registration studies in 5298 participants: A meta-analysis
Mitchell F Brin, Koen De Boulle, Steven Liew, et al.
Journal of the American Academy of Dermatology
|
October 23, 2024
Improvement of platysma prominence with onabotulinumtoxinA: Safety and efficacy results from a randomized, double-blinded, placebo-controlled phase 3 trial
Sabrina Fabi, Shannon Humphrey, Brian Biesman, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 17, 2020
Forehead Line Treatment With OnabotulinumtoxinA in Subjects With Forehead and Glabellar Facial Rhytids: A Phase 3 Study
Steven Fagien, Joel L Cohen, William Coleman, et al.
Aesthetic Surgery Journal
|
March 20, 2025
A Controlled Phase 2b Trial to Assess the Efficacy and Safety of a Single Intervention of OnabotulinumtoxinA for Treating Masseter Muscle Prominence
Steven Liew, Derek Jones, Steven Dayan, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 28, 2014
Efficacy and safety of onabotulinumtoxinA for the treatment of crows feet lines: a multicenter, randomized, controlled trial
Alastair Carruthers, Suzanne Bruce, Arlette de Coninck, et al.
Aesthetic Surgery Journal
|
August 22, 2025
Longitudinal Computed Tomography Indicates No Negative Impact of OnabotulinumtoxinA on Mandibular Bone Density in a 12-Month, Double-Blind, Randomized, Repeat Treatment, Placebo-Controlled Study in Healthy Adults With Masseter Muscle Prominence
Paul Kostenuik, Sanjay M Mallya, René Hopfinger, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
August 11, 2018
Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines
Koenraad De Boulle, William Philip Werschler, Michael H Gold, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 9, 2014
Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial
Marion Moers-Carpi, Jean Carruthers, Steven Fagien, et al.
Infectious Diseases in Clinical Practice (Baltimore, Md.)
|
September 20, 2021
Discontinuation of Transmission Precautions for COVID-19 Patients: Polymerase Chain Reaction Diagnostics, Patient Delays, and Cycle Threshold Values
Rahim A Jiwani, Yuxuan Mao, Adrian Pona, et al.
Page
of 4